|
Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial
The Lancet HIV
💎 10 分
|
Ming J Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, Simon Collins, Marcilio Fumagalli, Emanuela Falaschetti, Mohammed Altaf, Timothy Tipoe, Piyumika Godakandaarachi, Julie Fox, Alison Uriel, Amanda Clarke, Sabine Kinloch-de Loes, Sarah Pett, Marta Boffito, Gary Whitlock, Ole S Søgaard, Kyle Ring, Irvine Mangawa, Jesal Gohil, Tamara Elliott, Henrik Nielsen, Jesper Damsgaard Gunst, Chloe Orkin, Rebecca Sutherland, Lisa Hamzah, Paola Cicconi, Graham P Taylor, Jacquie Ujetz, Ishrat Jahan, Helen Brown, Nicola Robinson, Stephen Fletcher, Hanna Box, Kelly E Seaton, Georgia D Tomaras, Margaret E Ackerman, Joshua A Weiner, Anna Kaczynska, Cintia Bittar, Jill Horowitz, Michel C Nussenzweig, Marina Caskey, John Frater, Sarah Fidler
|
2026 |
10.1016/s2352-3018(26)00059-7
|
付费解锁 (10分)
|